JPMorgan Defends Aetna (AET), Remains Skeptical Co Will Face Material Consequences
Tweet Send to a Friend
JPMorgan maintains Overweight on Aetna (NYSE: AET).Analyst Gary Taylor is skeptical that the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


